Marvell Technology stock has jumped more than 30% since I rated it a buy roughly one month ago.
1 extracted signal · 1 resolved · 0 still active
Parkev Tatevosian, CFAIndependent analyst profile- Source published
- 10 Oct 2025, 18:45 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC

AI-generated source summary
The analysis focuses on Marvell Technology (MRVL), initiated on September 8th, where the analyst upgraded the stock to 'Buy' when it crashed. Over the last month, the stock price has increased by over 30%. According to the management team, Marvell delivered a record revenue of 2.006 billion, reflecting a 6% sequential increase and a 58% year-over-year increase, and data center and market grew up 69% due to AI demand. The analysis notes that Marvel is competing with Broadcom. They also delivered $462,000,000 in operating cash flow. The company repurchased $540,000,000 of stock in the first half of the fiscal year. After increasing, the fair value has also increased, although it is still below the current market value. The analyst is now updating the recommendation to 'Hold', due to the intrinsic value being $63.23, and since the current market price is $87.34.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
Parkev Tatevosian, CFA
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
